FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2893249868> ?p ?o ?g. }

• W2893249868 endingPage "63" @default.
• W2893249868 startingPage "57" @default.
• W2893249868 abstract "Introduction: The aim of this research was to study the impact of various doxorubicin (Dox)-containing nanofluids, e.g. singlewalled carbon nanotube (SWCNT)+Dox, graphene oxide (GO)+Dox and DextranPNIPAM (copolymer)+Dox mixtures on HeLa cells (human transformed cervix epithelial cells, as a model for cancer cells) depending on their concentration. Methods: Structural analysis of GO+Dox complex was accomplished using Hartree-Fock level of theory in 6-31G** basis set in Gaussian. Dynamic light scattering (DLS), zeta-potential, scanning electron microscopy and confocal laser scanning microscopy were used. The cell viability was analyzed by the MTT assay. Results: The viability of HeLa cells was studied with the MTT assay after the incubation with various Dox-containing dispersions depending on their concentration. The size of the particles was determined by DLS. The morphology of the nanoparticles (NPs) was studied by scanning electron microscopy and their uptake into cells was visualized by confocal laser scanning microscopy. It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells up to 80% after 24 hours of incubation, whereas the SWCNT+Dox and GO+Dox nanofluids at the same concentrations protected cells from Dox. Conclusion: The importance of Dextran-PNIPAM copolymer as a universal platform for drug delivery was established, and the huge potential of Dextran-PNIPAM+Dox NPs as novel anticancer agents was noted. Based on the in vitro study of the SWCNT+Dox and GO+Dox nanofluids, it was concluded that SWCNT and GO NPs can be effective cytoprotectors against the highly toxic drugs." @default.
• W2893249868 created "2018-10-05" @default.
• W2893249868 creator A5035977537 @default.
• W2893249868 creator A5039179709 @default.
• W2893249868 creator A5045396227 @default.
• W2893249868 creator A5070741076 @default.
• W2893249868 creator A5074631085 @default.
• W2893249868 creator A5075618885 @default.
• W2893249868 creator A5081925401 @default.
• W2893249868 creator A5088826989 @default.
• W2893249868 creator A5089688794 @default.
• W2893249868 creator A5090816374 @default.
• W2893249868 date "2018-10-14" @default.
• W2893249868 modified "2023-10-14" @default.
• W2893249868 title "In vitro study of the anticancer activity of various doxorubicin-containing dispersions" @default.
• W2893249868 cites W1804398254 @default.
• W2893249868 cites W1985498995 @default.
• W2893249868 cites W1990497572 @default.
• W2893249868 cites W1995153136 @default.
• W2893249868 cites W1995768709 @default.
• W2893249868 cites W2010943899 @default.
• W2893249868 cites W2014894986 @default.
• W2893249868 cites W2026395206 @default.
• W2893249868 cites W2036968634 @default.
• W2893249868 cites W2050091149 @default.
• W2893249868 cites W2050277244 @default.
• W2893249868 cites W2059503937 @default.
• W2893249868 cites W2065355693 @default.
• W2893249868 cites W2086166813 @default.
• W2893249868 cites W2088277794 @default.
• W2893249868 cites W2091777032 @default.
• W2893249868 cites W2176713976 @default.
• W2893249868 cites W2184569060 @default.
• W2893249868 cites W2203023800 @default.
• W2893249868 cites W2290662836 @default.
• W2893249868 cites W2317236306 @default.
• W2893249868 cites W2339509631 @default.
• W2893249868 cites W2473782794 @default.
• W2893249868 cites W2563585318 @default.
• W2893249868 cites W2594355827 @default.
• W2893249868 cites W2616278095 @default.
• W2893249868 cites W2739640136 @default.
• W2893249868 cites W2742788054 @default.
• W2893249868 cites W2767205284 @default.
• W2893249868 cites W2774044601 @default.
• W2893249868 cites W2774741385 @default.
• W2893249868 cites W2793515221 @default.
• W2893249868 cites W2793679661 @default.
• W2893249868 doi "https://doi.org/10.15171/bi.2019.07" @default.
• W2893249868 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6378100" @default.
• W2893249868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30788260" @default.
• W2893249868 hasPublicationYear "2018" @default.
• W2893249868 type Work @default.
• W2893249868 sameAs 2893249868 @default.
• W2893249868 citedByCount "15" @default.
• W2893249868 countsByYear W28932498682019 @default.
• W2893249868 countsByYear W28932498682020 @default.
• W2893249868 countsByYear W28932498682021 @default.
• W2893249868 countsByYear W28932498682022 @default.
• W2893249868 countsByYear W28932498682023 @default.
• W2893249868 crossrefType "journal-article" @default.
• W2893249868 hasAuthorship W2893249868A5035977537 @default.
• W2893249868 hasAuthorship W2893249868A5039179709 @default.
• W2893249868 hasAuthorship W2893249868A5045396227 @default.
• W2893249868 hasAuthorship W2893249868A5070741076 @default.
• W2893249868 hasAuthorship W2893249868A5074631085 @default.
• W2893249868 hasAuthorship W2893249868A5075618885 @default.
• W2893249868 hasAuthorship W2893249868A5081925401 @default.
• W2893249868 hasAuthorship W2893249868A5088826989 @default.
• W2893249868 hasAuthorship W2893249868A5089688794 @default.
• W2893249868 hasAuthorship W2893249868A5090816374 @default.
• W2893249868 hasBestOaLocation W28932498681 @default.
• W2893249868 hasConcept C12554922 @default.
• W2893249868 hasConcept C141071460 @default.
• W2893249868 hasConcept C14631669 @default.
• W2893249868 hasConcept C155672457 @default.
• W2893249868 hasConcept C171250308 @default.
• W2893249868 hasConcept C185592680 @default.
• W2893249868 hasConcept C192562407 @default.
• W2893249868 hasConcept C202751555 @default.
• W2893249868 hasConcept C2776694085 @default.
• W2893249868 hasConcept C2777339698 @default.
• W2893249868 hasConcept C2777366897 @default.
• W2893249868 hasConcept C2779178360 @default.
• W2893249868 hasConcept C2780783641 @default.
• W2893249868 hasConcept C2781303535 @default.
• W2893249868 hasConcept C43617362 @default.
• W2893249868 hasConcept C53227056 @default.
• W2893249868 hasConcept C55493867 @default.
• W2893249868 hasConcept C71924100 @default.
• W2893249868 hasConcept C86181022 @default.
• W2893249868 hasConcept C86803240 @default.
• W2893249868 hasConcept C95444343 @default.
• W2893249868 hasConceptScore W2893249868C12554922 @default.
• W2893249868 hasConceptScore W2893249868C141071460 @default.
• W2893249868 hasConceptScore W2893249868C14631669 @default.
• W2893249868 hasConceptScore W2893249868C155672457 @default.
• W2893249868 hasConceptScore W2893249868C171250308 @default.

• next